RICE HALL JAMES & ASSOCIATES, LLC - THERAPEUTICSMD INC ownership

THERAPEUTICSMD INC's ticker is TXMD and the CUSIP is 88338N107. A total of 145 filers reported holding THERAPEUTICSMD INC in Q4 2018. The put-call ratio across all filers is 1.22 and the average weighting 0.1%.

Quarter-by-quarter ownership
RICE HALL JAMES & ASSOCIATES, LLC ownership history of THERAPEUTICSMD INC
ValueSharesWeighting
Q1 2020$443,000
-66.2%
417,721
-23.0%
0.02%
-43.2%
Q4 2019$1,312,000
-37.4%
542,163
-6.1%
0.04%
-41.3%
Q3 2019$2,097,000
+43.8%
577,592
+3.0%
0.08%
+56.2%
Q2 2019$1,458,000
-43.7%
560,696
+5.4%
0.05%
-42.2%
Q1 2019$2,590,000
+560.7%
531,864
+417.0%
0.08%
+492.9%
Q4 2018$392,000102,8730.01%
Other shareholders
THERAPEUTICSMD INC shareholders Q4 2018
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 3,460,225$24,914,0004.95%
Newtyn Management, LLC 1,800,000$12,960,0001.95%
1492 Capital Management LLC 222,485$1,602,0001.25%
SANDERS MORRIS HARRIS LLC 967,200$6,964,0001.18%
MORGENS WATERFALL VINTIADIS & CO INC 180,000$1,296,0001.15%
SPHERA FUNDS MANAGEMENT LTD. 580,000$4,176,0000.82%
Rock Springs Capital Management LP 1,600,000$11,520,0000.66%
STONERIDGE INVESTMENT PARTNERS LLC 467,425$3,365,0000.45%
Capital Impact Advisors, LLC 157,411$1,133,0000.45%
GILDER GAGNON HOWE & CO LLC 3,059,690$22,030,0000.37%
View complete list of THERAPEUTICSMD INC shareholders